| 67.34 -0.17 (-0.25%) | 06-10 11:01 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 79.47 | 1-year : | 92.82 |
| Resists | First : | 68.04 | Second : | 79.47 |
| Pivot price | 63.86  |
|||
| Supports | First : | 62.91 | Second : | 59.74 |
| MAs | MA(5) : | 65.63 |
MA(20) : | 63.59 |
| MA(100) : | 71.03  |
MA(250) : | 80.42 |
|
| MACD | MACD : | 0.1 |
Signal : | -0.6 |
| %K %D | K(14,3) : | 91.8 |
D(3) : | 88.4 |
| RSI | RSI(14): 59.3 |
|||
| 52-week | High : | 96.73 | Low : | 59.74 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ MMSI ] has closed below upper band by 7.7%. Bollinger Bands are 5.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 68.05 - 68.28 | 68.28 - 68.5 |
| Low: | 65.63 - 65.93 | 65.93 - 66.21 |
| Close: | 67.02 - 67.45 | 67.45 - 67.84 |
Merit Medical Systems, Inc. (MMSI) is engaged in the design, development, manufacturing, and worldwide commercialization of disposable medical products. These devices are crucial for a broad spectrum of diagnostic, therapeutic, and interventional procedures, primarily within the fields of cardiology, radiology, oncology, critical care, and endoscopy. The company operates through two main divisions: Cardiovascular and Endoscopy. Its extensive product portfolio includes advanced solutions for diagnosing and treating conditions in peripheral vessels and organs, as well as a comprehensive suite of cardiac intervention products. The latter encompasses tools for vascular access, angiography, electrophysiology, cardiac rhythm management, fluid and hemodynamic monitoring, hemostasis, and various interventional therapies for heart-related ailments. Additionally, MMSI provides customized procedural solutions, offering critical care items, disinfection protection systems, specialized syringes, manifold kits, and tailored trays and packs. Their offerings further extend to coated tubes and wires, alongside sophisticated sensor components for microelectromechanical systems (MEMS). The company also features pulmonary products, such as laser-cut tracheobronchial stents with their accompanying over-the-wire and direct visualization delivery systems, and dilation balloons used for endoscopic stricture dilation. Gastroenterology products, as well as essential kits and accessories for endoscopy and bronchoscopy procedures, complete their diverse catalog. Merit Medical Systems sells its products to a wide client base, including hospitals and healthcare professionals (physicians, technicians, and nurses) working in alternative care settings. Distribution channels include a direct sales force, authorized distributors, original equipment manufacturer (OEM) partnerships, and custom procedure tray manufacturers, reaching customers throughout the United States and internationally. Founded in 1987, Merit Medical Systems, Inc. has its corporate headquarters situated in South Jordan, Utah.
Mon, 08 Jun 2026
Merit Medical Systems (MMSI) CLO reports charitable gift of 2,000 shares - Stock Titan
Mon, 08 Jun 2026
Is the Options Market Predicting a Spike in Merit Medical Systems Stock? - Zacks Investment Research
Mon, 08 Jun 2026
Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now - Yahoo Finance Singapore
Mon, 08 Jun 2026
Merit Medical Systems, Inc. (MMSI) Stock Analysis: Strong Buy Ratings and 38.87% Upside Potential - DirectorsTalk Interviews
Sat, 06 Jun 2026
A Look At Merit Medical Systems (MMSI) Valuation As Insider Buying Follows Undervaluation Claims - Sahm
Fri, 05 Jun 2026
A Look At Merit Medical Systems (MMSI) Valuation As Insider Buying Follows Undervaluation Claims - simplywall.st
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 60 (M) |
| Shares Float | 58 (M) |
| Held by Insiders | 2.4 (%) |
| Held by Institutions | 104.4 (%) |
| Shares Short | 2,880 (K) |
| Shares Short P.Month | 2,950 (K) |
| EPS | 2.31 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 27.27 |
| Profit Margin | 9 % |
| Operating Margin | 11.5 % |
| Return on Assets (ttm) | 4.7 % |
| Return on Equity (ttm) | 9.1 % |
| Qtrly Rev. Growth | 7.5 % |
| Gross Profit (p.s.) | 12.59 |
| Sales Per Share | 25.81 |
| EBITDA (p.s.) | 5.36 |
| Qtrly Earnings Growth | 38.7 % |
| Operating Cash Flow | 297 (M) |
| Levered Free Cash Flow | 178 (M) |
| PE Ratio | 28.93 |
| PEG Ratio | 1.3 |
| Price to Book value | 2.46 |
| Price to Sales | 2.59 |
| Price to Cash Flow | 13.45 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|